Smith & Nephew to acquire Zimmer’s Unicondylar Knee system in US market

LONDONJune 24, 2015 /PRNewswire/ — Smith & Nephew (NYSE: SNN; LSE:SN), the global medical technology business, today announced an agreement to acquire the Zimmer® Unicompartmental High Flex Knee (ZUK) system in the US market. ZUK is a clinically proven uni knee replacement introduced globally in 2004.  Smith & Nephew has purchased all existing inventory and certain intellectual property for the US market.

The transaction will close within three business days after the merger between Zimmer® and Biomet® has closed.

“Our acquisition of this product line expands our access to a fast growing segment of the joint reconstruction market,” says Brad Cannon, President of Global Orthopaedic Franchises. “We look forward to welcoming many new customers to Smith & Nephew and are excited by this opportunity to demonstrate first-hand our excellent customer service and broad range of advanced surgical products.”

Advertisement

Terms of the transaction were not disclosed.

About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic ReconstructionAdvanced Wound ManagementSports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 100 countries. Annual sales in 2013 were more than $4.3 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE:  SNN).

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement